These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of anti-Müllerian hormone in female fertility and infertility - an overview. Grynnerup AG; Lindhard A; Sørensen S Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322 [TBL] [Abstract][Full Text] [Related]
4. [Measurement of serum AMH levels in gynecology: indications and limits]. Streuli I; Cantero-Perez P; Miserez-Zaugg C Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018 [TBL] [Abstract][Full Text] [Related]
5. Is the measurement of anti-Müllerian hormone essential? Usta T; Oral E Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725 [TBL] [Abstract][Full Text] [Related]
6. The physiology and clinical utility of anti-Mullerian hormone in women. Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863 [TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone (AMH): what do we still need to know? La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS; Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713 [TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? La Marca A; Volpe A Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660 [TBL] [Abstract][Full Text] [Related]
9. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Kevenaar ME; Meerasahib MF; Kramer P; van de Lang-Born BM; de Jong FH; Groome NP; Themmen AP; Visser JA Endocrinology; 2006 Jul; 147(7):3228-34. PubMed ID: 16556768 [TBL] [Abstract][Full Text] [Related]
10. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions]. Yu M; Deng CY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075 [TBL] [Abstract][Full Text] [Related]
11. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders. Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness and indications of AMH assay in women]. Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664 [TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213 [TBL] [Abstract][Full Text] [Related]
14. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. Stubbs SA; Hardy K; Da Silva-Buttkus P; Stark J; Webber LJ; Flanagan AM; Themmen AP; Visser JA; Groome NP; Franks S J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171 [TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients. Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296 [TBL] [Abstract][Full Text] [Related]
16. [Level of AMH as a predictor of the result of ovarian stimulation]. Vrublovský P Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060 [TBL] [Abstract][Full Text] [Related]
17. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
19. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798 [TBL] [Abstract][Full Text] [Related]
20. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]